loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202800 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Aurolife Pharma LLC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AUROLIFE PHARMA LLC (3)

    filter

    01 TABLET;ORAL (3)

    filter

    01 RX (3)

    filter

    01 ACETAMINOPHEN AND CODEINE PHOSPHATE (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ACETAMINOPHEN; CODEINE PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    300MG;60MG
    2013-04-15
    202800
    ACETAMINOPHEN AND ...
    RX
    No
    AA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ACETAMINOPHEN; CODEINE PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    300MG;15MG
    2013-04-15
    202800
    ACETAMINOPHEN AND ...
    RX
    No
    AA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ACETAMINOPHEN; CODEINE PHOSPHATE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    300MG;30MG
    2013-04-15
    202800
    ACETAMINOPHEN AND ...
    RX
    No
    AA
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 202800

    Looking for FDA Orange Book APPLICATION 202800 3

    19

    Aurolife Pharma LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is ACETAMINOPHEN; CODEINE PHOSPHATE, with a corresponding application number 202800.

    Regulatory Information RX

    With a dosage strength 300MG;60MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2013-04-15

    Therapeutic Equivalence (TE) Code AA

    18

    Aurolife Pharma LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is ACETAMINOPHEN; CODEINE PHOSPHATE, with a corresponding application number 202800.

    Regulatory Information RX

    With a dosage strength 300MG;15MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2013-04-15

    Therapeutic Equivalence (TE) Code AA

    17

    Aurolife Pharma LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is ACETAMINOPHEN; CODEINE PHOSPHATE, with a corresponding application number 202800.

    Regulatory Information RX

    With a dosage strength 300MG;30MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2013-04-15

    Therapeutic Equivalence (TE) Code AA

    Post Enquiry
    POST ENQUIRY